Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion
Authors
Keywords
-
Journal
Hepatology International
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-30
DOI
10.1007/s12072-022-10431-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Primary biliary cholangitis
- (2021) Nora Cazzagon et al. CURRENT OPINION IN GASTROENTEROLOGY
- A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.
- (2021) Jörn M. Schattenberg et al. JOURNAL OF HEPATOLOGY
- Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
- (2021) Anna Reig et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Primary Biliary Cholangitis management: controversies, perspectives, and daily practice implications from an expert panel
- (2020) Domenico Alvaro et al. LIVER INTERNATIONAL
- Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis
- (2019) Akira Honda et al. HEPATOLOGY
- The challenges of primary biliary cholangitis: What is new and what needs to be done
- (2019) Benedetta Terziroli Beretta-Piccoli et al. JOURNAL OF AUTOIMMUNITY
- Primary biliary cholangitis: pathogenesis and therapeutic opportunities
- (2019) Aliya F. Gulamhusein et al. Nature Reviews Gastroenterology & Hepatology
- Current and potential treatments for primary biliary cholangitis
- (2019) Raj A Shah et al. Lancet Gastroenterology & Hepatology
- A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
- (2018) Christophe Corpechot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and Management of Primary Biliary Cholangitis
- (2018) Zobair M. Younossi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
- (2017) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Predicting risk in primary biliary cholangitis
- (2016) Bertus Eksteen HEPATOLOGY
- Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study
- (2014) Willem J. Lammers et al. GASTROENTEROLOGY
- Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study
- (2013) Li-Na Zhang et al. HEPATOLOGY
- Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome
- (2011) Christophe Corpechot et al. JOURNAL OF HEPATOLOGY
- Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis
- (2011) Njideka Momah et al. LIVER INTERNATIONAL
- Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis
- (2010) Teru Kumagi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
- (2009) Edith M.M. Kuiper et al. GASTROENTEROLOGY
- Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis
- (2009) Nobuaki Azemoto et al. JOURNAL OF GASTROENTEROLOGY
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
- (2009) JOURNAL OF HEPATOLOGY
- Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
- (2008) Christophe Corpechot et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started